Alexion Pharmaceuticals Inc. (ALXN) is set to report fourth-quarter 2018 earnings results on Monday, February 4, before market open. Wall Street expects
Categories
Health Care
Earnings preview: HIV to drive topline growth for Gilead Sciences in Q4
Biotechnology company Gilead Sciences (GILD) is scheduled to report fourth-quarter earnings results after the closing bell on Monday, February 4. The company
Merck’s stock gains after Q4 results beat estimates
Merck’s (MRK) shares climbed over 3% in morning trade on Friday after the company topped revenue and earnings expectations for the fourth
Cigna’s stock falls despite Q4 results beat
Cigna Corporation (CI) topped market expectations on revenue and earnings for the fourth quarter of 2018. Despite the beat, the stock fell
Celgene posts upbeat Q4 results, guidance
Celgene Corp. (CELG) swung to a profit in the fourth quarter from a loss last year, helped by lower research and development
Earnings preview: Merck to ride the wave of expanding oncology portfolio in Q4
The general market sentiment on Merck & Co. (MRK) is quite bullish ahead of the drug maker’s fourth-quarter earnings report. Analysts predict
Anthem’s stock gains 6% after Q4 results top expectations
Anthem Inc. (ANTM) reported better-than-expected revenue and earnings for the fourth quarter of 2018, sending the stock up over 6% in premarket
Amgen swings to profit in Q4, beats estimates
Amgen (AMGN) swung to a profit in the fourth quarter from a loss last year, helped by higher revenues, lower tax rate
Illumina Q4 earnings miss estimates
Gene-sequencing firm Illumina (NASDAQ: ILMN) reported mixed Q4 results. The company failed to beat street estimates on the earnings front due to
Biogen’s Q4 results beat estimates; revenues up 7%
Biogen Inc. (BIIB) reported revenue and earnings that surpassed market expectations for the fourth quarter of 2018. The stock was up 1.16%
Allergan’s stock falls after company reports loss in Q4
Allergan plc (AGN) saw its shares drop 4.2% in premarket hours on Tuesday after the company reported a GAAP net loss for
Earnings: Pfizer edges past Q4 estimates, shares dip on weak outlook
Pfizer (PFE) reported a better-than-expected 2% increase in fourth-quarter revenues to $13.9 billion. Earnings rose to 64 cents per share from 62
Earnings preview: Botox to drive Allergan’s growth in Q4
Allergan plc (AGN) is set to report its fourth-quarter 2018 earnings results on Tuesday, January 29, before market open. Analysts expect earnings
Amgen set to report Q4 earnings on Jan. 29. What’s in store?
Amgen (AMGN) will be reporting its fourth quarter and full-year 2018 earnings results on Tuesday, January 29 after market closes. Analysts expect
Earnings Preview: All eyes on the Pfizer-Glaxo JV
Pfizer Inc. (PFE) is scheduled to report earnings results for the fourth quarter of 2018 on Tuesday, January 29, before market open.
AbbVie slips to loss in Q4, misses estimates
AbbVie Inc. (ABBV) slipped to a loss in the fourth quarter from a profit last year, due to the inclusion of the
Bristol-Myers Squibb reports Q4 earnings on Jan 24. What to expect
Only two weeks after announcing its massive acquisition of Celgene Corporation, drug-maker Bristol-Myers Squibb (BMY) is all set to report fourth-quarter results
Abbott Laboratories swings to profit in Q4, beats estimates
Abbott Laboratories (ABT) swung to a profit in the fourth quarter from a loss last year, helped by a decline in tax
Abbott earnings preview: Pharma, medical devices to drive Q4 results
Healthcare giant Abbott Laboratories (ABT) is expected to post upbeat results for the fourth quarter on Wednesday before the bell, despite the
Johnson & Johnson Q4 Earnings: stellar pharma sales help deliver upbeat results
Healthcare giant Johnson & Johnson (JNJ) kicked off pharma earnings for the fourth-quarter as it posts higher-than-expected quarterly results on January 22,
Eli Lilly’s oncology push suffers a blow after sarcoma drug fails study
The ambitious cancer therapy program of Eli Lilly and Company (LLY) suffered a setback Friday after a formulation developed by the drug